E Fund Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $948K | Buy |
21,965
+3,075
| +16% | +$133K | 0.05% | 175 |
|
|
2025
Q1 | $653K | Buy |
18,890
+1,105
| +6% | +$38.2K | 0.03% | 202 |
|
|
2024
Q4 | $488K | Buy |
17,785
+2,151
| +14% | +$59K | 0.02% | 232 |
|
|
2024
Q3 | $398K | Sell |
15,634
-862
| -5% | -$21.9K | 0.02% | 221 |
|
|
2024
Q2 | $418K | Buy |
16,496
+1,785
| +12% | +$45.2K | 0.02% | 194 |
|
|
2024
Q1 | $455K | Sell |
14,711
-58
| -0.4% | -$1.79K | 0.03% | 170 |
|
|
2023
Q4 | $596K | Sell |
14,769
-1,326
| -8% | -$53.5K | 0.04% | 129 |
|
|
2023
Q3 | $424K | Sell |
16,095
-11,821
| -42% | -$311K | 0.03% | 156 |
|
|
2023
Q2 | $480K | Buy |
27,916
+12,700
| +83% | +$218K | 0.04% | 118 |
|
|
2023
Q1 | $252K | Sell |
15,216
-18,610
| -55% | -$308K | 0.02% | 261 |
|
|
2022
Q4 | $258K | Buy |
33,826
+476
| +1% | +$3.63K | 0.02% | 253 |
|
|
2022
Q3 | $331K | Sell |
33,350
-18,598
| -36% | -$185K | 0.03% | 219 |
|
|
2022
Q2 | $472K | Buy |
51,948
+20,684
| +66% | +$188K | 0.04% | 153 |
|
|
2022
Q1 | $317K | Buy |
+31,264
| New | +$317K | 0.01% | 183 |
|